On the other hand, the results also indicate that precise regulation of BRCA1 functions to avoid DNA repair in the nucleus but activate cell death signals in the cytoplasm might represent an attractive strategy for combined breast cancer therapies. This evidence concerns the gene BRCA1 and breast carcinoma.